Fenghe Li Selected Research

May-Thurner Syndrome

6/2021	The effect of stent compression on in-stent restenosis and clinical outcomes in iliac vein compression syndrome.
1/2020	Midterm outcome of pharmacomechanical catheter-directed thrombolysis combined with stenting for treatment of iliac vein compression syndrome with acute iliofemoral deep venous thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fenghe Li Research Topics

Disease

2	May-Thurner Syndrome 06/2021 - 01/2020
2	Thrombosis (Thrombus) 01/2020 - 06/2015
2	Hyperplasia 01/2018 - 09/2010
1	Thoracic Aortic Aneurysm 01/2022
1	Neoplasm Metastasis (Metastasis) 08/2021
1	Neoplasms (Cancer) 08/2021
1	Breast Neoplasms (Breast Cancer) 08/2021
1	Ischemia 01/2021
1	Pathologic Constriction (Stenosis) 01/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020
1	Thoracic Aorta Dissection 01/2020
1	Ulcer 01/2019
1	Venous Insufficiency 01/2019
1	Inflammation (Inflammations) 01/2018
1	Atherosclerosis 01/2018
1	Atherosclerotic Plaque (Atheroma) 01/2018
1	Neointima 01/2018
1	Vascular Remodeling 01/2018
1	Fibrosis (Cirrhosis) 01/2017
1	Reperfusion Injury 01/2017
1	Infections 06/2015
1	False Aneurysm (Pseudoaneurysm) 06/2015
1	Pulmonary Embolism 08/2014
1	Seroma 12/2013
1	Postoperative Pain 12/2013
1	Chronic Pain 12/2013
1	Hematoma 12/2013
1	Wound Infection (Wound Infections) 12/2013
1	Retinoblastoma (Glioblastoma, Retinal) 09/2010

Drug/Important Bio-Agent (IBA)

1	Apolipoprotein A-I (Apolipoprotein A1)IBA 08/2021
1	Scavenger Receptors (Scavenger Receptor)IBA 08/2021
1	Pharmaceutical PreparationsIBA 08/2021
1	Neuropilin-1IBA 08/2021
1	tLyP-1 peptideIBA 08/2021
1	HDL LipoproteinsIBA 08/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2021
1	Peptides (Polypeptides)IBA 08/2021
1	GANT 61IBA 08/2021
1	tyrosyl- 1,2,3,4- tetrahydro- 3- isoquinolinecarbonyl- phenylalanyl- phenylalanine (TIPP)IBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2018
1	NADP (NADPH)IBA 01/2018
1	Proline (L-Proline)FDA Link 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2015
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 08/2014
1	CyclinsIBA 09/2010
1	Cyclin EIBA 09/2010
1	cyclopamineIBA 09/2010
1	Cyclin D1IBA 09/2010

Therapy/Procedure

5	Stents 01/2022 - 06/2015
2	Length of Stay 01/2021 - 12/2013
1	Endovascular Procedures 01/2021
1	Thrombectomy 01/2020
1	Catheters 01/2020
1	Ligation 01/2018
1	Debridement 06/2015
1	Sutures (Suture) 12/2013